Home › Funds › B Group, Inc. › DRUG

B Group, Inc. position in DRUG

BRIGHT MINDS BIOSCIENCES INC · Health Care

B Group, Inc. reported holding 95,000 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 2.92% of its reported portfolio and ranking #14 among its reported holdings. B Group, Inc. has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)95.00K sh
Reported value held$4.73M
Portfolio Weight2.92%
First reportedQ1 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How B Group, Inc.'s DRUG position evolved

B Group, Inc. first disclosed a stake in DRUG in Q1 2026 at 67,500 shares (US$4.9M). Across 3 filings, B Group, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 95,000 shares valued at US$4.7M — an increase of 27,500 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2026 (shares fell 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 67.50K $4.93M New
Q2 2026 67.50K $4.74M Hold
Q3 2026 95.00K $4.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRUG and 13F data

DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 64 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vestal Point Capital, LP (US$38.3M), BRAIDWELL LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRUG

All DRUG fund holders →

FAQ

How long has B Group, Inc. held DRUG?

B Group, Inc. has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is B Group, Inc.'s current position in DRUG?

As of Q3 2026, B Group, Inc. holds 95.00K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $4.73M, representing 2.92% of its reported portfolio and ranking #14.

Has B Group, Inc. been buying or selling DRUG?

In the latest 13F filing (Q3 2026), B Group, Inc. increased its position in DRUG.

Which other funds hold DRUG?

Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vestal Point Capital, LP, BRAIDWELL LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.